ArticleVaccines2022

Evaluation of Commercial Myxomatosis Vaccines against Recombinant Myxoma Virus (ha-MYXV) in Iberian Hare and Wild Rabbit.

Fábio A Abade Dos Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.